Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
PaxMedica, Inc. (PXMD) had Stock-Based Compensation of $5.21M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-18.29M |
|
-- |
|
-- |
|
$16.15M |
|
$-16.15M |
|
$-2.14M |
|
$-18.29M |
|
$-18.29M |
|
$-18.29M |
|
$-18.29M |
|
$-18.29M |
|
$-18.29M |
|
$-16.15M |
|
$-16.15M |
|
1.66M |
|
1.66M |
|
$-11.00 |
|
$-11.00 |
|
| Balance Sheet Financials | |
$5.68M |
|
-- |
|
-- |
|
$5.68M |
|
$1.80M |
|
-- |
|
$0.50M |
|
$2.30M |
|
$3.39M |
|
$3.39M |
|
$3.39M |
|
7.40M |
|
| Cash Flow Statement Financials | |
$-10.77M |
|
-- |
|
$13.58M |
|
$1.90M |
|
$4.71M |
|
$2.81M |
|
|
Stock-Based Compensation |
$5.21M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-540.31% |
|
-540.31% |
|
-321.98% |
|
-540.31% |
|
$0.46 |
|
$-6.48 |
|
$-6.48 |
|